Simple jQuery Dropdowns

Browsing by Author Institut Bergonie

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
1-Jul-2018Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A clinical trialMelanie Royce; Thomas Bachelot; Cristian Villanueva; Mustafa Özgüroglu; Sergio J. Azevedo; Felipe Melo Cruz; Marc Debled; Roberto Hegg; Tatsuya Toyama; Carla Falkson; Joon Jeong; Vichien Srimuninnimit; William J. Gradishar; Christina Arce; Antonia Ridolfi; Chinjune Lin; Fatima Cardoso; Champalimaud Foundation; Yonsei University Health System; University of New Mexico; Istanbul Üniversitesi; Centre Hospitalier Universitaire de Besancon; The University of Alabama at Birmingham; Le Centre Régional de Lutte Contre le Cancer Léon Bérard; Hospital de Clinicas de Porto Alegre; Novartis Pharma S.A.S.; Northwestern University Feinberg School of Medicine; Faculty of Medicine, Siriraj Hospital, Mahidol University; Universidade de Sao Paulo - USP; Institut Bergonie; Nagoya University; Novartis Pharmaceuticals Corporation; Instituto Brasileiro de Controle do Câncer
1-May-2016Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trialA. Hochhaus; G. Saglio; T. P. Hughes; R. A. Larson; D. W. Kim; S. Issaragrisil; P. D. Le Coutre; G. Etienne; P. E. Dorlhiac-Llacer; R. E. Clark; I. W. Flinn; H. Nakamae; B. Donohue; W. Deng; D. Dalal; H. D. Menssen; H. M. Kantarjian; Universitatsklinikum Jena und Medizinische Fakultat; Università degli Studi di Torino; The University of Adelaide; University of Chicago; The Catholic University of Korea; Mahidol University; Charité – Universitätsmedizin Berlin; Institut Bergonie; Universidade de Sao Paulo - USP; Royal Liverpool and Broadgreen University Hospitals NHS Trust; Sarah Cannon Research Institute; Osaka City University; Novartis Pharmaceuticals Corporation; Novartis International AG; University of Texas MD Anderson Cancer Center
17-Jun-2010Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemiaGiuseppe Saglio; Dong Wook Kim; Surapol Issaragrisil; Philipp Le Coutre; Gabriel Etienne; Clarisse Lobo; Ricardo Pasquini; Richard E. Clark; Andreas Hochhaus; Timothy P. Hughes; Neil Gallagher; Albert Hoenekopp; Mei Dong; Ariful Haque; Richard A. Larson; Hagop M. Kantarjian; Universita degli Studi di Torino; The Catholic University of Korea; Mahidol University; Charité – Universitätsmedizin Berlin; Institut Bergonie; Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti; Universidade Federal do Parana; Royal Liverpool and Broadgreen University Hospitals NHS Trust; Universitatsklinikum Jena und Medizinische Fakultat; Royal Adelaide Hospital; Novartis International AG; Novartis Pharmaceuticals; University of Chicago; University of Texas MD Anderson Cancer Center
15-May-2017Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept studyPhilippe Rousselot; Stéphane Prost; Joelle Guilhot; Lydia Roy; Gabriel Etienne; Laurence Legros; Aude Charbonnier; Valérie Coiteux; Pascale Cony-Makhoul; Francoise Huguet; Emilie Cayssials; Jean Michel Cayuela; Francis Relouzat; Marc Delord; Heriberto Bruzzoni-Giovanelli; Laure Morisset; François Xavier Mahon; François Guilhot; Philippe Leboulch; Universite de Versailles Saint-Quentin-en-Yvelines; CEA Fontenay aux Roses; Centre Hospitalier Universitaire de Poitiers; Hôpital Henri Mondor; Institut Bergonie; Centre Hospitalier Universitaire de Nice; Institut Paoli-Calmettes; Centre Hospitalier Regional Universitaire de Lille; Centre Hospitalier Annecy Genevois; Institut Universitaire du Cancer; Hôpital Saint-Louis; Universite Paris 7- Denis Diderot; CHV Centre Hospitalier de Versailles; Hopital Haut-Lévêque C.H.U de Bordeaux; Brigham and Women's Hospital and Harvard Medical School; Mahidol University